Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MUROMONAB-CD3: 114 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
114
Total FAERS Reports
28 (24.6%)
Deaths Reported
28
Hospitalizations
114
As Primary/Secondary Suspect
4
Life-Threatening

First Report: 1996 · Latest Report: 201403

What Are the Most Common MUROMONAB-CD3 Side Effects?

#1 Most Reported
Post transplant lymphoproliferative disorder
22 reports (19.3%)
#2 Most Reported
Infection
16 reports (14.0%)
#3 Most Reported
Cytomegalovirus infection
13 reports (11.4%)

All MUROMONAB-CD3 Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Post transplant lymphoproliferative disorder 22 19.3% 3 14
Infection 16 14.0% 6 3
Cytomegalovirus infection 13 11.4% 5 4
Cytomegalovirus oesophagitis 10 8.8% 1 0
Drug resistance 10 8.8% 1 0
Duodenitis 10 8.8% 1 1
Gastritis 10 8.8% 1 1
Weight decreased 10 8.8% 1 0
Chest pain 9 7.9% 1 0
Cytomegalovirus chorioretinitis 9 7.9% 0 0
Cytomegalovirus infection reactivation 9 7.9% 1 0
Encephalitis 9 7.9% 1 0
Gastric fistula 9 7.9% 1 0
Gastric ulcer 9 7.9% 1 0
Gastrointestinal ulcer 9 7.9% 1 0
Haematemesis 9 7.9% 1 0
Human herpesvirus 6 infection 9 7.9% 0 0
Malnutrition 9 7.9% 1 0
Oesophageal ulcer 9 7.9% 1 0
Oesophagopleural fistula 9 7.9% 1 0

Who Reports MUROMONAB-CD3 Side Effects? Age & Gender Data

Gender: 45.0% female, 55.0% male. Average age: 30.2 years. Most reports from: US. View detailed demographics →

Is MUROMONAB-CD3 Getting Safer? Reports by Year

YearReportsDeathsHosp.
2004 1 0 1
2014 1 1 0

View full timeline →

What Is MUROMONAB-CD3 Used For?

IndicationReports
Immunosuppressant drug therapy 38
Prophylaxis against transplant rejection 20
Prophylaxis against graft versus host disease 13
Immunosuppression 12
Transplant rejection 12
Product used for unknown indication 11
Bone marrow conditioning regimen 8
Allogenic stem cell transplantation 5

MUROMONAB-CD3 vs Alternatives: Which Is Safer?

MUROMONAB-CD3 vs MYCOPHENOLATE MUROMONAB-CD3 vs MYCOPHENOLATE MOFETIL MUROMONAB-CD3 vs MYCOPHENOLATE MOFETIL\MYCOPHENOLATE MOFETIL MUROMONAB-CD3 vs MYCOPHENOLIC ACID MUROMONAB-CD3 vs MYFORTIC MUROMONAB-CD3 vs MYRBETRIQ MUROMONAB-CD3 vs NABILONE MUROMONAB-CD3 vs NABUMETONE MUROMONAB-CD3 vs NADOFARAGENE FIRADENOVEC-VNCG MUROMONAB-CD3 vs NADOLOL

Official FDA Label for MUROMONAB-CD3

Official prescribing information from the FDA-approved drug label.